BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 27270345)

  • 1. Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
    Stannard JN; Kahlenberg JM
    Curr Opin Rheumatol; 2016 Sep; 28(5):453-9. PubMed ID: 27270345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cutaneous lupus erythematosus: current approaches and future strategies.
    Shi H; Gudjonsson JE; Kahlenberg JM
    Curr Opin Rheumatol; 2020 May; 32(3):208-214. PubMed ID: 32141953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetics of cutaneous lupus erythematosus.
    Hersh AO; Arkin LM; Prahalad S
    Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment.
    Hejazi EZ; Werth VP
    Am J Clin Dermatol; 2016 Apr; 17(2):135-46. PubMed ID: 26872954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lupus erythematosus: update of therapeutic options part I.
    Kuhn A; Ruland V; Bonsmann G
    J Am Acad Dermatol; 2011 Dec; 65(6):e179-93. PubMed ID: 20739095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological therapies in the treatment of cutaneous lupus erythematosus.
    Presto JK; Hejazi EZ; Werth VP
    Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
    Zhang YP; Wu J; Han YF; Shi ZR; Wang L
    Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.
    Lee HJ; Sinha AA
    Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
    Kuhn A; Aberer E; Bata-Csörgő Z; Caproni M; Dreher A; Frances C; Gläser R; Klötgen HW; Landmann A; Marinovic B; Nyberg F; Olteanu R; Ranki A; Szepietowski JC; Volc-Platzer B
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):389-404. PubMed ID: 27859683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on pathogenesis and treatment of CLE.
    Privette ED; Werth VP
    Curr Opin Rheumatol; 2013 Sep; 25(5):584-90. PubMed ID: 23872903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
    Nutan F; Ortega-Loayza AG
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S64-S68. PubMed ID: 28941497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus.
    Robinson ES; Werth VP
    Cytokine; 2015 Jun; 73(2):326-34. PubMed ID: 25767072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous and systemic connections in lupus.
    Maz MP; Michelle Kahlenberg J
    Curr Opin Rheumatol; 2020 Nov; 32(6):583-589. PubMed ID: 32826479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
    Yu C; Chang C; Zhang J
    J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous lupus erythematosus: The impact of self-amplifying innate and adaptive immune responses and future prospects of targeted therapies.
    Fetter T; Wenzel J
    Exp Dermatol; 2020 Nov; 29(11):1123-1132. PubMed ID: 32633821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Lupus Erythematosus: Progress and Challenges.
    Petty AJ; Floyd L; Henderson C; Nicholas MW
    Curr Allergy Asthma Rep; 2020 Apr; 20(5):12. PubMed ID: 32248318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cutaneous lesions in patients with lupus erythematosus.
    Callen JP
    Dermatol Clin; 1994 Jan; 12(1):201-6. PubMed ID: 8143382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of
    Gardet A; Pellerin A; McCarl CA; Diwanji R; Wang W; Donaldson D; Franchimont N; Werth VP; Rabah D
    Front Immunol; 2019; 10():275. PubMed ID: 30846987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.